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Leukoencephalopathy with cerebral 
calcifications and cyst: Labrune syndrome
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The association of leukoencephalopathy with cerebral cal-
cifications and cysts (LCC), Labrune syndrome is a rare dis-
ease, which was first described in 19961. LCC is derived from 
the syndrome called COATS plus or cerebroretinal microan-
giopathy with calcifications and brain cysts (CRMCC), report-
ed in 1988. We report a case of an adult patient with LCC.
CaSE REpoRT
Patient, male, 31 years-old, son of non-consanguineous 
parents, and no perinatal complications, he presents a history 
of tonic-clonic seizures for seven years. Previously healthy, he 
sought assistance after the first seizure, showing no changes 
in neurological examination in post-crisis. The patient had 
complete blood count, renal and hepatic function, glucose, 
electrolytes, serology for HIV and toxoplasma gondii negative. 
Fig. (A) Brain MRI showing brain cysts in the right hemisphere with midline shift, compression of the lateral ventricles, and 
white matter changes; (B) MRI with two brain cysts in the right hemisphere and white matter changes; (C) CT scan showing 
calcifications in the basal ganglia.
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Electrocardiogram and cardiac enzymes were normal. In that 
occasion, the computed tomography (CT) scan showed a bi-
lateral calcification located in the basal ganglia (Fig C). Brain 
magnetic resonance imaging (MRI) showed extensive area of 
leukodistrophia and cysts in both hemispheres, the largest 
measuring 6.7 versus 4.8 cm, with marginal enhancement af-
ter intravenous contrast. The repeated MRI showed progres-
sion of the lesions (Fig A and B). 
In the same month, the largest brain cyst was surgically 
removed, and the histopathological examination of the cyst 
showed foci of dystrophic calcifications and focal accumula-
tions of macrophages xanthomized. There were no signs of ma-
lignancy in the sample. The patient evolved with partial control 
of seizures using carbamazepine 1,800 mg/day and he also per-
formed five surgeries to remove brain cysts. Now, the patient is 
currently with neurological examination demonstrating cogni-
tive syndrome characterized by a transcortical motor aphasia; 
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pyramidal syndrome characterized by incomplete hemiparesis 
on the right hemibody. Myotatic exalted reflexes in the right 
hemibody and plantar-cutaneous reflex were indifferent. 
DiSCuSSion
Reviewing the relevant literature worldwide, Labrune syn-
drome was considered as a possible diagnosis for the present 
case2. Despite the presence of cysts, calcification, and edema 
of the white substance found in our patient, suggesting neu-
rocysticercosis, equinecocosis3 or neoplasia, there was no se-
rologic or histopathologic confirmation.
This syndrome is characterized by calcifications, leu-
kodystrophy, and formation of parenchymal cysts1. Its onset 
can occur during childhood or adolescence, in an average of 
12 years (7 months – 59 years), but there was not one in adults 
in Brazil, with neurological signs such as cognitive decline, 
seizures and pyramidal, extrapyramidal or cerebellar signs1,2. 
Our patient, unlike the other cases reported in literature, 
presented its first neurological manifestation at the age of 24. 
CT and MRI seen in our case were similar to the cases re-
ported in literature, showing increased signal intensity of the 
white matter on MRI (T2 and FLAIR), basal ganglia calcifica-
tion, and development of cysts1-3.
Labrune reported the results of histopathology with re-
arrangement involving the microvessels, whereas perivas-
cular foci of calcifications, hyaline deposits, and formation 
of Rosenthal fibers seem to be compatible with this change1. 
The histopathological findings of our patient were consistent 
with LCC. According to them, the likely primary pathologic 
feature is a rearrangement involving the microvessels and the 
formation of Rosenthal fibers1,4.
In conclusion, the etiology of LCC remains unknown. In 
spite of relatively characteristic findings in imaging and histo-
pathological examination, there is no uniformity in the clini-
cal findings noted in the published articles. It can be specu-
lated that the later age of onset, normal intelligence and slow 
progression, like in our patient, may indicate the shape of this 
rare disease in adults.
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A 33-year-old woman (registration 70-247/ IPUB-
UFRJ) has had recurring headaches since the age of 18. 
She described more right-sided than left-sided throbbing, 
which could be severe and associated with nausea, light 
and noise sensitivity, and vomiting. She has had a visual 
aura, seeing “zig-zags”, lasting for 20 to 30 minutes before 
the headaches. The only preventive measure she had tak-
en in the past was divalproex sodium, with good efficacy. 
Because of the weight gain as a side effect, she refused to 
take it again. Her body mass index (BMI) was 35.3. She 
was started on preventive therapy with topiramate at 25 
mg daily for two weeks that was to be increased weekly 
